作者: Jimmi Nielsen
DOI: 10.1007/978-94-007-0834-1_13
关键词: Population 、 Intervention (counseling) 、 Psychiatry 、 Dyslipidemia 、 Schizophrenia 、 Diabetes mellitus 、 Metabolic syndrome 、 Antipsychotic 、 Medicine 、 Obesity
摘要: Patients with schizophrenia have a lifespan that is more than 20 years less of the general population. It has been suggested treatment antipsychotics reason for their reduced lifespan, but patients are also known to sedentary and unhealthy lifestyle, including heavy smoking, inactivity obesity. Some antipsychotic medications increase risk diabetes dyslipidemia, but, on other hand, suboptimal increases not only suicide violent behaviour. Furthermore, it likely seek medical help somatic diseases. This chapter discusses illnesses associated its focus monitoring intervention in order reduce mortality.